Could Microbial Metabolites Redefine Precision Nutrition?

For years, microbiome research has focused on which microbes inhabit our gut. But perhaps the most important question is no longer who is there. It is what they produce. At the 13th World Congress on Targeting Microbiota 2026, Dr. Cristina Menni from King's College London, UK, and the University of Milan, Italy, will explore how microbial metabolites provide the functional link between diet, the gut microbiome and human health.

Drawing on large population studies, including the TwinsUK cohort, her research demonstrates how metabolomics is moving the field beyond descriptive microbiome profiling toward functional biomarkers capable of improving disease prediction, monitoring dietary interventions and advancing personalised nutrition.

Could microbial metabolites become the key biomarkers that finally bridge diet, the microbiome and precision medicine?

As nutrition science evolves, integrating metabolomics, microbiome science and dietary data has the potential to transform the prevention and management of cardiometabolic diseases.

Researchers working on microbial metabolites, metabolomics, nutrition, cardiometabolic health, precision nutrition and host–microbiome interactions are invited to submit their latest research to the 13th World Congress on Targeting Microbiota, Málaga, Spain, November 4–5, 2026.

The future of personalised nutrition may depend less on identifying microbes and more on understanding the molecules they produce.

For more information: LinkedIn